View
248
Download
2
Embed Size (px)
Citation preview
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
1/97
Herpesviridae HSV 1,2 and VZV
Dr.T.V.Rao MD
Dr.T.V.Rao MD 1
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
2/97
Herpesviridae The Herpesviridae are a large family
of DNA viruses that cause diseases in
animals, including humans The familyname is derived from the Greek wordherpein ("to creep"), referring to thelatent , re-occurring infections typicalof this group of viruses.Herpesviridae can cause latent or lyticinfections.
Dr.T.V.Rao MD 2
http://en.wikipedia.org/wiki/Lytic_cyclehttp://en.wikipedia.org/wiki/Lytic_cycle8/6/2019 Herpes Viridae HSV 1 and 2 VZV
3/97
Herpes Viruses DNA group Most important
Human Pathogens Wide Host cell range Life Long Infection
Periodic reactivation Immunocompromised
Large number ofgenes,
Some virusessusceptible totreatment. Dr.T.V.Rao MD 3
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
4/97
Alphaherpesvirinae Herpes simplex virus type 1 HSV-1 Herpes simplex virus type 2 HSV-2
Varicella-zoster virus VZV Betaherpesvirinae
cytomegalovirus CMV
Human herpesvirus type 6 HHV-6 Human herpesvirus type 7 HHV-7
Gammaherpesvirinae
Epstein-Barr virus EBV
CLASSIFICATION(Human pathogens)
Dr.T.V.Rao MD 4
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
5/97
Infecting Humans.Herpes Simplex virus 1 and 2Varicella Zoster VirusesCytomegalovirus virusEpstein Barr virusHuman Herpes viruses 6, 7.Kaposi's Sarcoma associated
Viruses Dr.T.V.Rao MD 5
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
6/97
Properties of HerpesViruses.
Spherical in Shape Icosahedral 150
to 200 nm in size Genome Double
stranded DNALinear
Envelope containsGlycoprotein's
Dr.T.V.Rao MD 6
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
7/97
Out Standing Characteristics
Encode many enzymes. Cause Latent Infections. Indefinite persistence. Relation in
Immunocompromised. Relation to Cancers.
Dr.T.V.Rao MD 7
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
8/97
Herpes Virus ReplicationReplicates in Host Cell NucleusForm Cow dry A Type inclusionbodies.More than 50 different types proteins
in infected cell.Large number of enzymes in DNAsynthesis
Dr.T.V.Rao MD 8
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
9/97
Herpes Simplex1 and 2
Dr.T.V.Rao MD 9
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
10/97
Herpesviridae Group:Group I
Family: Herpesviridae Subfamily: Alphaherpesvirinae Genus: Simplexvirus
Species Herpes simplex
virus 1 (HWJ-1)Herpes simplex virus 2 (HWJ-2)
Dr.T.V.Rao MD 10
http://en.wikipedia.org/wiki/Herpesviridaehttp://en.wikipedia.org/wiki/Herpesviridaehttp://en.wikipedia.org/wiki/Alphaherpesvirinaehttp://en.wikipedia.org/wiki/Alphaherpesvirinaehttp://en.wikipedia.org/wiki/Alphaherpesvirinaehttp://en.wikipedia.org/wiki/Alphaherpesvirinaehttp://en.wikipedia.org/wiki/Herpesviridaehttp://en.wikipedia.org/wiki/Herpesviridae8/6/2019 Herpes Viridae HSV 1 and 2 VZV
11/97
Herpes Simplex Virus
HSV arespherical inshape
Ds DNA 35 protein s
Dr.T.V.Rao MD 11
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
12/97
Human Herpes Virus 1 and 2
They are also called Human Herpes Virus 1 and 2 (HHV-1 and HHV-2 ) and areneurotropic and neuroinvasive viruses;
they enter and hide in the human nervoussystem, accounting for their durability inthe human body. HSV-1 is commonlyassociated with herpes outbreaks of theface known as cold sores or fever blisters,whereas HSV-2 is more often associatedwith genital herpes.
Dr.T.V.Rao MD 12
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
13/97
Pathogenesis of HSV 1 &2
Initialinfection
siteMigration through Neuron
replication Sensory ganglia
latency
Reactivation is t hrough stress stimulisuch as UV light, fever,
hormonal changes,surgical trauma to the neuron
HSV-1: trigeminal gangliaHSV-2: sacral ganglia
Antibodies do not prevent reactivation
Dr.T.V.Rao MD 13
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
14/97
Infections in Humans.( HerpesSimplex 1 and 2 )
Wide spread in Humans Broad Host Ranges. Replicate in Many types of Cells. Produce cytolytic effects Most Common Diseases. Gingival stomatitis, Kerato conjunctivitis Encephalitis Genital diseases, New Born Infections, Latent Infections in Nerve
Cells, Recurrence.
Dr.T.V.Rao MD 14
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
15/97
HERPES SIMPLEX VIRUS (HSV )
HSV 1 infect the upper part of thebody
- mouth and the face HSV 2 infect the lower part of the
body- genital infections
There is little cross protection
Therefore, one can get both theinfections Dr.T.V.Rao MD 15
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
16/97
Properties of Herpes Simplex Viruses
Type 1 and 2
Similar in Organization Restriction Enzyme Differentiates H S V 1 contact with Saliva. H S V 2 Sexual Maternal infection ( Genital Infection
spreads to New Born ) Replicates in 8-16 hours.
Dr.T.V.Rao MD 16
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
17/97
Out characters of Herpesgroup of viruses
Out standing characters 1 Encode many enzymes Latent infections are common Persist indefinitely in infected hosts. Frequent reactivation in infected hosts Some care cancer causing.
Dr.T.V.Rao MD 17
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
18/97
About 75% of the adults show +ve for HSV 1 infection HSV 1 infections include
-i. Oropharyngeal
. Children - very painful. due to kissing of elders
. acute gingivostomatitis
. problem of feeding
Dr.T.V.Rao MD 18
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
19/97
Virus Grows in thefollowing .
Primary and Continues Cell lines. Monkey and Rabbit Kidney, Human Amnion Syncytial formation and Giant cell
formations Multiplies in Chorio Allontoic membrane Monoclonal Antibodies differentiates
Type 1 and 2 types.Dr.T.V.Rao MD 19
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
20/97
Sources of infection
- Saliva- Skin lesions
Oropharyngeallesions
- Carriers
Dr.T.V.Rao MD 20
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
21/97
Transmission Close contact Skin and epithelial contact, Defects in Mucosal membrane Multiples Locally, Enters through cutaneous nerve fibers Intraaxonally to Ganglion
Centrifugal Migration Recurrent manifestation in Skin and Mucosa.
Dr.T.V.Rao MD 21
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
22/97
Dr.T.V.Rao MD 22
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
23/97
Pathogenesis. Most Common Human Viral Infection Causes cytolytic effect causes the
necrosis of cells. Infects Skin and Mucous membrane Cowdry type A inclusions are produced Multinucleated Giant cells are
demonstrated
Dr.T.V.Rao MD 23
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
24/97
Pathogenesis
Entry by skin or mucous membranes
viral multiplication sensory nerve
lysis of cells root ganglia
vesicles latency
ulcersREACTIVATION
COLDFEVER
SURGERYUNKNOWN
Dr.T.V.Rao MD 24
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
25/97
Dr.T.V.Rao MD 25
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
26/97
Predisposition of LatentInfection in
Ganglion Trigeminal HSV 1 Sacral HSV 2 Immunity. Cell Mediated ( CMI ) Predisposing Factors
Axonal InjuryPhysical and Emotional stress
U V light80% Adults harbour Antibodies to HSV
Dr.T.V.Rao MD 26
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
27/97
Dr.T.V.Rao MD 27
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
28/97
Dr.T.V.Rao MD 28
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
29/97
Dr.T.V.Rao MD 29
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
30/97
Dr.T.V.Rao MD 30
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
31/97
Clinical Manifestations Oropharyngeal Disease Buccal Gingival
Mucosa Incubation 3 to 5 days
May last for 2-3 weeks Gingvo stomatitis Sub mandibular
lymphadenopathy
Present with painful ulcers.
Dr.T.V.Rao MD 31
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
32/97
Recurrent Blisters in Herpes simplex 1
Dr.T.V.Rao MD 32
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
33/97
Herpes lesions in the oral
cavity
Dr.T.V.Rao MD 33
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
34/97
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
35/97
Herpes simplex 1 infecting eye
Dr.T.V.Rao MD 35
H 2 d i
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
36/97
Herpes 2 producingGenital Lesions
Dr.T.V.Rao MD 36
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
37/97
Skin Infections Infect abrasions
Dentists, ( HerpeticWhitlow) Health careworkers,
Eczema , Burns
Dr.T.V.Rao MD 37
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
38/97
Neonatal Herpes.
In Uterus At Birth After Birth. Delivery By Caesarean
SectionReduces the Infection
Dr.T.V.Rao MD 38
l f l
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
39/97
Neonatal Infection Normaldelivery
Dr.T.V.Rao MD 39
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
40/97
Other Manifestations. Meningitis, Encephalitis Multi organ Involvement Increased incidence in Immune
compromised AIDS, Haematological Malignancies.
Dr.T.V.Rao MD 40
R t i f ti i HSV
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
41/97
Recurrent infections in HSV1 and 2
Dr.T.V.Rao MD 41
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
42/97
Immunity
Mothers Ig G protects for 6 months. Primarily Ig M Later Ig g produced.
Main Participants in Immunity.C M I and Killer Cells and
Interferon play major role inimmunity
Dr.T.V.Rao MD 42
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
43/97
Laboratory Diagnosis
Microscopy, Antigen Detection DNA detection PCR. Viral Isolation. Serology
Dr.T.V.Rao MD 43
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
44/97
Laboratory Diagnosis Specimen: Vesicular fluid- Corneal scrapping1- Direct Virus Demonstration:a) L/M:
1. Tzanck smear from the base of vesicles,1% aq. soln. of toluidine blue O shows multinucleated giant cells with faceted
nuclei & homogenously stained ground glasschromatin (Tzanck cells)
2. Giemsa stained smear intranuclear Cowdry typeA inclusion bodies
Dr.T.V.Rao MD 44
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
45/97
B) Direct Immunofluorescence: Cell scrapings from lesions are stained
with monoclonal antibodies conjugatedwith a fluorescence dye. Viralinclusion bodies appear in UVmicroscope as a bright greenIntranuclear particles
Dr.T.V.Rao MD 45
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
46/97
2- Viral Isolation: tissue culture: humandiploid fibroblasts, human amnion, humanembryonic kidney: CPC (syncytiumformation) seen in 24-48 hrs.
3) Serology : useful in the diagnosis ofprimary infection, Ab (IgM) detection byELISA, NT or CFT.
Dr.T.V.Rao MD 46
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
47/97
Childhood infectionscommon
Second peak at onset ofsexual activity
Viral shedding persons with recurrences infected but asymptomatic
persons
Laboratory diagnosis
Dr.T.V.Rao MD 47
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
48/97
Useful genital & eye infections HVZ & HSV in immunocompromised
patients
herpes encephalitis Specimens
aspirate from vesicle
scraping from base of ulcer serum / CSF for antibody
Dr.T.V.Rao MD 48
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
49/97
Microscopy, Tzanck Smear Intranuclear
Type A InclusionBodies Electron
Microscopy Fluorescent
AntibodyDr.T.V.Rao MD 49
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
50/97
Specimens for Diagnosis.
Saliva. CSF Vesiclefluid.
Dr.T.V.Rao MD 50
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
51/97
Viral Isolation in Chick embryo In Tissue
CulturesPrimary
Embryonic
KidneyHuman
AmnionDr.T.V.Rao MD 51
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
52/97
Serology, ELISA Test Neutralization
Tests Complement
FixationTests
Dr.T.V.Rao MD 52
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
53/97
Chemotherapy Idoxuridine used topically in eye and skin
infections first successful antiviralagent.
Acyclovir and vidarabine helps insystemic infections
Other Drugs Valaciclovir, Famiciclovir, Orally effective Foscarnet.
Dr.T.V.Rao MD 53
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
54/97
Epidemiology. World Wide Distribution HSV 1 early in life 6 months to 3 years. 70% to 90% Adults have Antibodies Poor Living Conditions HSV 2 Sexually transmitted. Risk to mother and fetus Abortions < 20 weeks gestation HSV 2 increases predisposition to HIV infection
Dr.T.V.Rao MD 54
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
55/97
Varicella Zoster
Dr.T.V.Rao MD 55
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
56/97
History of Chickenpox
The namechicken poxbecause theblisters thatappeared
seemed like theskin that hasbeen pecked by the chicken..
Dr.T.V.Rao MD 56
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
57/97
Herpes Virus
Dr.T.V.Rao MD 57
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
58/97
Properties of Virus.
Like Herpes
Virus Icosahedrons
shape dsDNA
Dr.T.V.Rao MD 58
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
59/97
Varicella Zoster ( Herpes Virus)DNA Virus
Varicella -Chickenpox.
Contagious Disease
Mainly ChildrenGeneralized Vesicular
eruptionson Skin and Mucous
membranesSevere manifestations in
Adults and Immunecompromised. Dr.T.V.Rao MD 59
HERPES VARICELLA ZOSTER
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
60/97
HVZ Causes chicken pox -fever + characteristic rash variable incubation period 14-21 days usually mild in children and more severe in adults complications
secondary infection - uncommon varicella pneumonia secondary bacterial pneumonia S aureus &
pneumococci post-infetious encephalitis generalised varicella (in immunocompromised patients) congenital and neonatal varicella
Dr.T.V.Rao MD 60
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
61/97
Dr.T.V.Rao MD 61
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
62/97
Varicella (Chicken Pox) Mild, highly contagious
disease chieflyaffecting children
Mode of transmission:
- airborne droplets anddirect contact fromvaricella patients
- Vesicular fluid ofZoster patients can bethe source of Varicellain susceptible children
Dr.T.V.Rao MD 62
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
63/97
Shingles (Herpes Zoster )
Rash Limited to Distribution of SingleSensory GanglionIn Adults and immune compromised
Sporadic
Dr.T.V.Rao MD 63
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
64/97
Varicella Zoster Virus (VZV)
Causes 2 majordiseases
Varicella (chickenpox): primaryinfection usually inchildhood
Zoster ( shingles):reactivation of anearlier varicella
Dr.T.V.Rao MD 64
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
65/97
Dr.T.V.Rao MD 65
HERPES VARICELLA ZOSTER
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
66/97
HVZ Causes chicken pox -fever + characteristic rash variable incubation period 14-21 days usually mild in children and more severe in adults complications
secondary infection - uncommon varicella pneumonia secondary bacterial pneumonia S aureus &
pneumococci post-infectious encephalitis generalized varicella (in immunocompromised patients) congenital and neonatal varicella
Dr.T.V.Rao MD 66
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
67/97
Herpes Zoster Primary
Contact -
Chicken Pox Reactivation
- Zoster(PartiallyImmune )
Dr.T.V.Rao MD 67
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
68/97
Culturing virus Grows in
Human embryonic TissueProduce inclusion bodiesNo difference in virusIn Chicken pox and
zoster infectionDr.T.V.Rao MD 68
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
69/97
Pathogenesis and Pathology Varicella virus enter through
URT/Conjunctiva.
Lymph nodes ViremiaLiver and spleen
Secondary viremiaInfects Mononuclear CellsRash Vesicle formationDr.T.V.Rao MD 69
Pathogenesis :
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
70/97
Pathogenesis : VZV infects the mucosa of the upper
respiratory tract Multiplies in the regional LNs Primary viremia and spread to liver and
spleen Secondary viremia follows with viral
spread to the skin
Typical rash occurs VZV remains latent in the dorsal root
ganglia for lifeDr.T.V.Rao MD 70
Clinical Picture:
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
71/97
Clinical Picture: Incubation period: 10-21 days Symptoms: mild fever & rash Rash: first appears on the trunk, then faceand limbs Flat macules become papules then vesicles Followed by crust formation
The crust is often shed off and healswithout scarring Cropping is a characteristic feature of
varicella rash: fresh vesicles appear in crops,
so that all stages of macules, papules,vesicles & crusts are seen at the same time More severe in adults
Dr.T.V.Rao MD 71
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
72/97
Dr.T.V.Rao MD 72
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
73/97
Herpes Zoster Skin Lesions Inflammation of
Sensory Nervesand Ganglia Single Ganglion Dorsal root
Ganglion
Dr.T.V.Rao MD 73
Entry of Varicella Zoster
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
74/97
Entry of Varicella Zostervirus
Dr.T.V.Rao MD 74
Skin lesions showing different
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
75/97
Skin lesions showing differentstages
Dr.T.V.Rao MD 75
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
76/97
Clinical Findings. Varicella, Incubation 10-20 days Fever, Malaise
Rash Trunk
Face
Limbs
Buccal andPharyngeal mucosa Lesions at all stages
Macules, Papules, Vesicles, Crusts,May last 5 days, Hundreds of eruptions.
Dr.T.V.Rao MD 76
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
77/97
Skin lesions of chickenpox
Dr.T.V.Rao MD 77
Chicken pox lesions in the
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
78/97
Chicken pox lesions in thebuccal cavity
Dr.T.V.Rao MD 78
Herpes Zoster involving a
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
79/97
Herpes Zoster involving aNerve segment
Dr.T.V.Rao MD 79
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
80/97
Congenital Varicella Syndrome & Neonatal
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
81/97
Congenital Varicella Syndrome & NeonatalVaricella
Primary maternal infection during the 1 st trimester may lead to congenitalvaricella syndrome ( serious & fatal): skinlesions, hypoplasia of limbs, chorioretinitis &
CNS defects Primary maternal infection near the timeof birth can lead to widely disseminatedinfection in the new born with mortalityrate of 35%
If rash began a week or more before delivery,maternal Abs transferred via placenta baby getsthe infection but escapes clinical disease
Dr.T.V.Rao MD 81
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
82/97
Immune compromised HIV / AIDS Malignancies.
Organtransplantations Corticosteroid
usage Leukaemia's .
Dr.T.V.Rao MD 82
HERPES VARICELLA ZOSTER
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
83/97
HVZ Causes chicken pox -fever + characteristic rash variable incubation period 14-21 days usually mild in children and more severe in adults complications
secondary infection - uncommon varicella pneumonia secondary bacterial pneumonia S aureus &
pneumococci post-infectious encephalitis generalized varicella (in immunocompromised patients) congenital and neonatal varicella
Dr.T.V.Rao MD 83
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
84/97
Pain and hyperaesthesia
Dr.T.V.Rao MD 84
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
85/97
Pain and hyperaesthesia
Dr.T.V.Rao MD 85
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
86/97
Pain and hyperaesthesia
Dr.T.V.Rao MD 86
HERPES ZOSTER
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
87/97
Reactivation of HVZ
dermatomal distribution may recur can disseminate in immunocompromised patients complications
post herpetic pain ophthalmic zoster -corneal scarring and loss of vision
DIAGNOSIS
CLINICALEM of vesicle fluid
SEROLOGY
IgM detectionDr.T.V.Rao MD 87
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
88/97
Zoster.
Associated with Immunecompromised.
Manifest with severe pain Vesicles on trunk , head, neck
Trigeminal Neuralgia
Dr.T.V.Rao MD 88
( hi l )
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
89/97
Zoster (shingles)
Sporadic disease inadults orimmunocompromisedpatients
Results fromreactivation of latentVZV
Rash similar tovaricella but limited to
a nerve distribution tothe skin innervated bya dorsal root ganglion(dermatom)
Dr.T.V.Rao MD 89
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
90/97
Pain and hyperaesthesia
Dr.T.V.Rao MD 90
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
91/97
Other Complications.
Encephalitis, Mother to Child
transmission Varicella Pneumonia. Fatal Complications .
Dr.T.V.Rao MD 91
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
92/97
Laboratory Diagnosis. Smears --Scrapings from Lesions
Demonstration of Multi nucleated giant cellsTzanck smears
DNA DemonstrationCell cultures,Fluorescent antibodyELISA PCR
Dr.T.V.Rao MD 92
Epidemiology
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
93/97
Communicable Disease World wide prevalence
Common in < 10 year olds. Zoster in Adults
Droplet spread
Dr.T.V.Rao MD 93
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
94/97
Treatment Specific treatment is indicated mainly
in Immunodeficient and elderlysubjects and also in complicated withVaricella pneumonia,encephalitis,anddisseminated zoster
Acyclovir and Famiciclovir.
Dr.T.V.Rao MD 94
Prevention of Chickenpox
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
95/97
Susceptible populationchildren
adults living in close proximity
Do nothing
Immunizelive attenuated
vaccine
Protect if contact with patient with chickenpoxand at risk of severe diseaseZoster Immune Globulin (ZIG)Dr.T.V.Rao MD 95
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
96/97
Vaccine available A live modified Varicella virus
lyophilised vaccine which can bestored at low temp is availablefor protection
Children 1 -12 years given single
dose. >12 years 2 doses 2 -6 weeks
apart High titre serum from
convalescing from herpes zoster
protect Immunocompromisedchildren.
But not useful for treatment
Dr.T.V.Rao MD 96
8/6/2019 Herpes Viridae HSV 1 and 2 VZV
97/97
Programme created by Dr.T.V.Rao MD forMedical and Paramedical Students in the
Developing World